Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / IR INNOVATE RESEARCH PRIVATE LIMITED

Clinicaltrial registered5 Nov 2026

IR INNOVATE RESEARCH PRIVATE LIMITED

5 Nov 2026: Trial registered · Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
5 Nov 2026
Title
Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
Conditions
Acne
Phase
Phase 4
Study Type
Interventional
Status
Recruiting
Countries
Vietnam
Country
Vietnam
Reference
NCT07918001
Location
Vietnam
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at IR INNOVATE RESEARCH PRIVATE LIMITED

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Vietnam

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.